Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. E. M. Wilkie, J. D. Chalmers, R. J. Stretton, S. Schembri, R. P. Smith (Dundee, United Kingdom). Validation of a novel prognostic tool for idiopathic pulmonary fibrosis. Eur Respir J 2012; 40: Suppl. 56, 3612

Member's Comments

No comment yet.

Related content which might interest you: A simple prognostic tool for idiopathic pulmonary fibrosis (IPF) Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 A novel prognostic signature based on five-immune-related genes for idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021 Potential new biomarkers for idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Evaluation of recently validated non-invasive formula using basic lung functions as a new screening tool for pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 A simple assessment of dyspnea as a prognostic indicator in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis Source: Eur Respir J, 50 (1) 1700379; 10.1183/13993003.00379-2017 Year: 2017 Dyspnoea: a prognostic marker for idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 37: 476 Year: 2011 Proof of concept of a non-invasive screening tool to detect idiopathic pulmonary fibrosis (IPF) in an early stage Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Prognostic evaluation in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis Source: Eur Respir J 2010; 36: 1067-1072 Year: 2010 Prognostic evaluation in Chinese patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Development and feasibility of an eHealth tool for idiopathic pulmonary fibrosis Source: Eur Respir J, 51 (3) 1702508; 10.1183/13993003.02508-2017 Year: 2018 Genetic predictors of idiopathic pulmonary fibrosis (IPF) prognosis Source: Eur Respir J 2006; 28: Suppl. 50, 830s Year: 2006 Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Fibulin-1 is a novel biomarker of disease severity in pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis Year: 2010 Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (3) 00019-2016; 10.1183/23120541.00019-2016 Year: 2017 Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery Source: Eur Respir Rev 2013; 22: 148-152 Year: 2013